Stock listing
NASDAQ:SOMX Somaxon Pharmaceuticals Inc Stock
Follow Somaxon Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:SOMX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SOMX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Somaxon Pharmaceuticals Inc on 6ix
- Decks
- 13 decks · latest Jun 15, 2011
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (June 2011) | Technical | 17 slides | Jun 15, 2011 |
| Investor Presentation (May 2011) | Investor deck | 18 slides | May 24, 2011 |
| 13th Annual BIO CEO & Investor Conference (February 2011) | Conference | 22 slides | Feb 14, 2011 |
| UBS Global Life Science Conference 2010 | Conference | 22 slides | Sep 21, 2010 |
| BMO Capital Markets 10th Annual Focus on Healthcare Conference (August 2010) | Conference | 29 slides | Aug 5, 2010 |
| BIO CEO & Investor Conference 2010 | Conference | 26 slides | Feb 8, 2010 |
| Rodman & Renshaw 11th Annual Healthcare Conference (September 2009) | Conference | 32 slides | Sep 8, 2009 |
| Technical Presentation (June 2008) | Technical | 6 slides | Jun 12, 2008 |
| Technical Presentation (June 2008) | Technical | 21 slides | Jun 12, 2008 |
| Investor Presentation (January 2008) | Investor deck | 33 slides | Jan 7, 2008 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2006) | Investor deck | 36 slides | Nov 28, 2006 |
| Investor Presentation (October 2006) | Investor deck | 29 slides | Oct 31, 2006 |
| Investor Presentation (April 2006) | Investor deck | 20 slides | Apr 11, 2006 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Faheem Hasnain Other companies: Aspen Neuroscience, Inc. (Executive Chair, Director · Since at least Nov 2, 2026); Gossamer Bio, Inc. (President & CEO, Director · Since at least Feb 7, 2019); Kura Oncology, Inc. (Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past) | Director · Sep 16, 2010 – Dec 31, 2012 · Past |
| Jesse I Treu Other companies: CoLucid Pharmaceuticals Inc (Director · May 5, 2015 – May 11, 2015 · Past); Aldeyra Therapeutics, Inc. (Director · May 1, 2014 – Jun 9, 2020 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Feb 28, 2019 · Past); Tobira Therapeutics Inc (Director · Aug 21, 2013 – Jan 1, 2015 · Past) | Director · Mar 3, 2010 – Jun 9, 2010 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past) | Director · Apr 2, 2012 – Dec 31, 2012 · Past |
| Richard W Pascoe Other companies: Histogen Inc (President, CEO & Director, Director · May 26, 2020 – Mar 30, 2021 · Past); Zevra Therapeutics, Inc. (Chief Executive Officer, Director · Apr 15, 2015 – Mar 9, 2023 · Past); Apricus Biosciences Inc (CEO & Secretary, Director · Mar 18, 2013 – Jan 23, 2019 · Past) | President and CEO, Director · Nov 28, 2008 – Dec 31, 2012 · Past |
| Tran Nguyen Other companies: Prothena Corporation plc (Chief Strategy Officer and CFO · Since at least Mar 25, 2013); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Sierra Oncology Inc (Director · Mar 18, 2016 – Jun 11, 2019 · Past) | SVP and CFO · Apr 12, 2010 – Dec 31, 2012 · Past |
| Michael D Allen | SVP, Sales and Marketing · Sep 30, 2011 – Sep 30, 2011 · Past |
Log in to ask 6ix AI your own questions about Somaxon Pharmaceuticals Inc.